AVIEW vs ClearRead CT
AI Verdict
Choose AVIEW if…
Choose AVIEW if your institution requires a comprehensive AI platform for multi-faceted lung health assessment, including detailed lung cancer screening, COPD quantification, and Interstitial Lung Disease (ILD) pattern analysis. Its robust features for 3D visualizations, automated segmentation, and follow-up registration make it ideal for in-depth diagnostic precision and longitudinal patient monitoring across various deployment environments.
View AVIEW →Choose ClearRead CT if…
Choose ClearRead CT if your primary goal is to significantly enhance the accuracy and efficiency of pulmonary nodule detection in CT scans, particularly benefiting from patented vessel suppression technology. This tool is best suited for radiology departments aiming to reduce reading times by up to 36% and improve the detection of actionable nodules, streamlining workflows with its focus on clear visual intelligence and automated nodule tracking.
View ClearRead CT →For physicians evaluating AI tools for cardiothoracic imaging, AVIEW and ClearRead CT offer distinct strengths. AVIEW, from Coreline Soft, provides a comprehensive platform for lung cancer, COPD, and coronary artery calcification detection and monitoring. Its key features include detailed lung nodule characterization with Lung-RADS scoring, emphysema quantification, and automated segmentation of various anatomical structures. AVIEW also offers ILD pattern analysis and robust 3D visualizations with comprehensive PDF reports, making it suitable for practices requiring in-depth quantitative analysis and multi-faceted reporting across several pulmonary conditions.
ClearRead CT by Riverain Technologies focuses on enhancing pulmonary nodule detection and coronary artery calcification analysis, emphasizing improved diagnostic accuracy and reduced reading times. A key practical difference is its patented Vessel Suppression technology, which aims to provide clearer visualization of nodules by minimizing obscuring vessels. While both tools offer nodule tracking and CAC scoring, ClearRead CT highlights its ability to reduce missed actionable nodules and streamline workflows, potentially benefiting practices prioritizing efficiency and a focused approach to nodule detection. Physicians seeking a broad, quantitative platform for multiple lung conditions might lean towards AVIEW, while those prioritizing enhanced nodule visibility and workflow efficiency, particularly in high-volume settings, may find ClearRead CT more aligned with their needs.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AVIEW | ClearRead CT |
|---|---|---|
| Pricing | Subscription; one-off payment | Contact for pricing |
| Deployment | Cloud-based; Hybrid solution; Locally on dedicated hardware; Locally virtualized (virtual machine, Docker) | On-premise (stand-alone server, virtual machine) and Cloud |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
ClearRead CTClearRead CT demonstrates superior usability through its patented vessel suppression technology, which provides an unimpaired view of the lung, directly aiding radiologists in interpretation. Furthermore, it integrates seamlessly into PACS workflows without requiring separate applications or logins, significantly reducing reading times and improving efficiency.
Clinical Value
AVIEWAVIEW offers a broader clinical scope, providing comprehensive solutions for lung cancer, COPD, coronary artery calcification, and Interstitial Lung Disease (ILD) pattern analysis. Its AVIEW 2.0 platform further enhances value by delivering up to 89% faster case throughput and 60% reduction in interpretation time, consolidating multi-disease assessment into a streamlined workflow.
Pricing & Value
AVIEWAVIEW provides a more transparent pricing structure, offering both subscription and one-off payment options based on installations or users. This clarity allows potential customers to better understand and evaluate the cost-effectiveness of the solution upfront, which enhances perceived value.
Enterprise Readiness
AVIEWAVIEW explicitly states HIPAA compliance in its specifications and offers a wider range of deployment options, including cloud, hybrid, dedicated hardware, and virtualized solutions, providing greater flexibility for diverse enterprise IT environments. While ClearRead CT operates with stringent institutions like the VA and is ISO27001 certified, AVIEW's explicit HIPAA claim and broader deployment choices give it a slight edge in overall enterprise adaptability.
Innovation
ClearRead CTClearRead CT stands out with its patented Vessel Suppression (Clear Visual Intelligence) technology, a unique innovation that fundamentally improves image clarity by removing obscuring vascular structures. This distinct technological advancement directly contributes to its proven improvements in detection accuracy and reading efficiency, making it a highly impactful innovation in medical imaging.
Support & Docs
ClearRead CTRiverain Technologies provides clear and accessible support resources for ClearRead CT, including direct customer care contact information (email, phone, support tickets), FAQs, system requirements, workflow guides, and user manuals. This comprehensive and readily available documentation and support structure is not as explicitly detailed for AVIEW's medical imaging product in the provided information.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AVIEW | ClearRead CT |
|---|---|---|
| Lung Nodule Detection & Characterization | AI-powered lung nodule detection and characterization (size, volume, type, location, Lung-RADS score) | Pulmonary Nodule Detection (solid, part-solid, ground glass); Nodule Characterization and Measurement (volume, diameter, location, type, depth) |
| Coronary Artery Calcification (CAC) Scoring | Coronary artery calcium (CAC) scoring (Agatston, volume, mass score, risk stratification) | Coronary Artery Calcification (CAC) Scoring (ungated, non-contrast CTs) |
| Workflow Integration & Nodule Tracking | Workflow automation and integration with PACS/RIS/CIS; Follow-up registration and nodule matching for serial CT scans | Automated Nodule Tracking and Comparison to Prior Exams; Seamless PACS Integration / Vendor-neutral processing |
| Vessel Suppression Technology | Not specified | Patented Vessel Suppression (Clear Visual Intelligence) |
| Emphysema Quantification | Emphysema quantification and low attenuation area (LAA) analysis | Not specified |
Videos
Demos, reviews, and walkthroughs featuring AVIEW and ClearRead CT.